Valuation: LifeVantage Corporation

Market Cap 83.52M 73.23M 67.5M 63.19M 118M 7.88B 121M 811M 314M 3.89B 314M 307M 13.5B P/E 2026 *
15.8x
P/E 2027 * 17x
Enterprise Value 69.97M 61.35M 56.55M 52.94M 99.27M 6.6B 101M 680M 263M 3.26B 263M 257M 11.31B EV / Sales 2026 *
0.38x
EV / Sales 2027 * 0.38x
Free-Float
83.58%
Yield 2026 *
-
Yield 2027 * -
1 day-0.45%
1 week+3.28%
Current month-15.88%
1 month-4.47%
3 months+54.31%
6 months+9.06%
Current year+7.47%
1 week 5.8
Extreme 5.8
7
1 month 5.52
Extreme 5.52
11.71
Current year 3.9
Extreme 3.9
11.71
1 year 3.9
Extreme 3.9
15
3 years 3.9
Extreme 3.9
27.38
5 years 3.04
Extreme 3.04
27.38
10 years 2.86
Extreme 2.86
27.38
Manager TitleAgeSince
Chief Executive Officer 74 2026-04-29
Director of Finance/CFO 53 2021-10-24
Chief Tech/Sci/R&D Officer - 2026-01-06
Director TitleAgeSince
Director/Board Member 74 2011-12-31
Director/Board Member 67 2017-01-31
Director/Board Member 68 2022-02-16
Date Insider Type Main position Quantity % Market Cap.
06-14Buy

Director

705 0.0056%
06-02Sell

Chief Executive Officer

-10,000 0.0793%
03-31Tax

Chief Financial Officer

1,527 0.0119%
Change 5-day change 1-year change 3-year change Capi.($)
-0.45%+3.28%-48.40%+58.37% 83.52M
+7.13%+9.97%+51.94%+166.83% 1,077B
+3.99%+11.50%+67.53%+55.63% 613B
+4.20%+17.03%+35.63%+87.74% 448B
+0.99%+4.85%+27.93%+22.82% 332B
+1.82%+8.19%+41.15%+26.80% 293B
+0.22%+6.75%+31.51%+42.02% 286B
+0.73%+8.53%-26.22%-40.85% 215B
+1.56%+6.14%+28.38%+59.45% 193B
+3.26%+3.33%+18.83%+67.03% 159B
Average +1.81%+7.53%+22.83%+54.58% 361.62B
Weighted average by Cap. +2.26%+8.93%+40.51%+81.28%

Financials

2026 *2027 *
Net sales 184M 161M 149M 139M 261M 17.37B 267M 1.79B 692M 8.59B 692M 677M 29.78B 178M 156M 144M 135M 253M 16.83B 258M 1.73B 670M 8.32B 670M 655M 28.84B
Net income 5.3M 4.65M 4.28M 4.01M 7.52M 500M 7.68M 51.48M 19.92M 247M 19.9M 19.47M 857M 4.9M 4.3M 3.96M 3.71M 6.95M 462M 7.1M 47.6M 18.42M 228M 18.4M 18M 792M
Net Debt -13.55M -11.88M -10.95M -10.25M -19.23M -1.28B -19.62M -132M -50.93M -632M -50.88M -49.77M -2.19B -15M -13.15M -12.12M -11.35M -21.28M -1.41B -21.72M -146M -56.36M -699M -56.31M -55.08M -2.42B
Logo LifeVantage Corporation
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Employees
235
Date Price Change Volume
26-06-26 US$6.620 -0.45% 1,702,362
26-06-25 US$6.650 +6.74% 172,979
26-06-24 US$6.230 +0.81% 144,093
26-06-23 US$6.180 +1.64% 233,149
26-06-22 US$6.080 -5.15% 324,564
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.620USD
Average target price
7.000USD
Spread / Average Target
+5.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFVN Stock